Aster DM Healthcare’s shares surged by 11.21%, gaining ₹45.05 to trade at ₹447.05 on the NSE as of 10:22 AM. The sharp rise comes after the release of the company’s impressive Q2 FY25 results, which highlighted strong financial performance.
Stock Price Details:
- Open: ₹430.00
- High: ₹457.90
- Low: ₹422.35
- Previous Close: ₹402.00
Key reasons for the stock surge:
- Strong revenue growth:
Aster DM Healthcare reported a 17% year-on-year (YoY) increase in revenue, reaching ₹11,216.8 million in Q2 FY25, compared to ₹9,332.1 million in the same quarter last year. This strong growth in revenue has boosted investor confidence. - Net income recovery:
The company swung to a net profit of ₹968.4 million in Q2 FY25, a significant recovery from a net loss of ₹308 million in Q2 FY24, further strengthening the positive sentiment around the stock. - Improved operating margins:
Aster DM achieved a notable improvement in its operating margin, which expanded by 460 basis points (bps) YoY, indicating better cost management and efficiency gains. - Earnings Per Share (EPS) growth:
The basic EPS from continuing operations increased to ₹1.94, up from ₹0.94 in the same quarter last year, further showcasing the company’s strong financial performance.
For the first half of FY25, Aster DM’s total sales reached ₹20,883.1 million, up from ₹17,706.4 million a year earlier, while net income surged to ₹52,420.2 million from a net loss of ₹258.9 million during the same period last year.
Investors are responding positively to the company’s turnaround, driving the stock higher in today’s trading.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Please consult a qualified financial advisor before making any investment decisions.
